The role of EBV in the pathogenesis of Burkitt’s Lymphoma: an Italian hospital based survey
The exact worldwide incidence of Burkitt’s lymphoma is not known. There are three distinct clinical variants of Burkitt’s lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and th...
Saved in:
| Published in | Infectious agents and cancer Vol. 9; no. 1; p. 34 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
15.10.2014
BioMed Central Ltd |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1750-9378 1750-9378 |
| DOI | 10.1186/1750-9378-9-34 |
Cover
| Abstract | The exact worldwide incidence of Burkitt’s lymphoma is not known. There are three distinct clinical variants of Burkitt’s lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt’s lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt’s lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt’s lymphomas occurs in children (age range 3–12), and 8 were adulthood Burkitt’s lymphomas (age range 18–87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients.
Considering ISH for EBER detection results:
– 1 out 2 (50%) adult analyzed cases was positive, with 50% of stained tumor cells (this patient was a 22 years old female, coming from Napoli);
– 15 out 24 (62.5%) children analyzed Burkitt’s lymphomas resulted as positive for EBER;
– the overall positivity has been observed in 16/26 Burkitt’s lymphomas (61.53%).
– Finally, EBV has been detected in children and adult patients, one of them with deregulation of the oncogene c-MYC by chromosomal translocation. |
|---|---|
| AbstractList | The exact worldwide incidence of Burkitt's lymphoma is not known. There are three distinct clinical variants of Burkitt's lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt's lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt's lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt's lymphomas occurs in children (age range 3-12), and 8 were adulthood Burkitt's lymphomas (age range 18-87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients. The exact worldwide incidence of Burkitt's lymphoma is not known. There are three distinct clinical variants of Burkitt's lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt's lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt's lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt's lymphomas occurs in children (age range 3-12), and 8 were adulthood Burkitt's lymphomas (age range 18-87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients. Considering ISH for EBER detection results: - 1 out 2 (50%) adult analyzed cases was positive, with 50% of stained tumor cells (this patient was a 22 years old female, coming from Napoli); - 15 out 24 (62.5%) children analyzed Burkitt's lymphomas resulted as positive for EBER; - the overall positivity has been observed in 16/26 Burkitt's lymphomas (61.53%). - Finally, EBV has been detected in children and adult patients, one of them with deregulation of the oncogene c-MYC by chromosomal translocation. The exact worldwide incidence of Burkitt's lymphoma is not known. There are three distinct clinical variants of Burkitt's lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt's lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt's lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt's lymphomas occurs in children (age range 3-12), and 8 were adulthood Burkitt's lymphomas (age range 18-87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients. Considering ISH for EBER detection results: 1 out 2 (50%) adult analyzed cases was positive, with 50% of stained tumor cells (this patient was a 22 years old female, coming from Napoli);15 out 24 (62.5%) children analyzed Burkitt's lymphomas resulted as positive for EBER;the overall positivity has been observed in 16/26 Burkitt's lymphomas (61.53%).Finally, EBV has been detected in children and adult patients, one of them with deregulation of the oncogene c-MYC by chromosomal translocation. The exact worldwide incidence of Burkitt’s lymphoma is not known. There are three distinct clinical variants of Burkitt’s lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt’s lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt’s lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt’s lymphomas occurs in children (age range 3–12), and 8 were adulthood Burkitt’s lymphomas (age range 18–87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients. Considering ISH for EBER detection results: – 1 out 2 (50%) adult analyzed cases was positive, with 50% of stained tumor cells (this patient was a 22 years old female, coming from Napoli); – 15 out 24 (62.5%) children analyzed Burkitt’s lymphomas resulted as positive for EBER; – the overall positivity has been observed in 16/26 Burkitt’s lymphomas (61.53%). – Finally, EBV has been detected in children and adult patients, one of them with deregulation of the oncogene c-MYC by chromosomal translocation. The exact worldwide incidence of Burkitt's lymphoma is not known. There are three distinct clinical variants of Burkitt's lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt's lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt's lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt's lymphomas occurs in children (age range 3-12), and 8 were adulthood Burkitt's lymphomas (age range 18-87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients. Considering ISH for EBER detection results: - 1 out 2 (50%) adult analyzed cases was positive, with 50% of stained tumor cells (this patient was a 22 years old female, coming from Napoli); - 15 out 24 (62.5%) children analyzed Burkitt's lymphomas resulted as positive for EBER; - the overall positivity has been observed in 16/26 Burkitt's lymphomas (61.53%). - Finally, EBV has been detected in children and adult patients, one of them with deregulation of the oncogene c-MYC by chromosomal translocation. Keywords: Burkitt's lymphoma, Immunohistochemistry, In situ hybridization The exact worldwide incidence of Burkitt’s lymphoma is not known. There are three distinct clinical variants of Burkitt’s lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt’s lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt’s lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt’s lymphomas occurs in children (age range 3–12), and 8 were adulthood Burkitt’s lymphomas (age range 18–87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients. Considering ISH for EBER detection results: 1 out 2 (50%) adult analyzed cases was positive, with 50% of stained tumor cells (this patient was a 22 years old female, coming from Napoli); 15 out 24 (62.5%) children analyzed Burkitt’s lymphomas resulted as positive for EBER; the overall positivity has been observed in 16/26 Burkitt’s lymphomas (61.53%). Finally, EBV has been detected in children and adult patients, one of them with deregulation of the oncogene c-MYC by chromosomal translocation. Doc number: 34 Abstract: The exact worldwide incidence of Burkitt's lymphoma is not known. There are three distinct clinical variants of Burkitt's lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt's lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt's lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt's lymphomas occurs in children (age range 3-12), and 8 were adulthood Burkitt's lymphomas (age range 18-87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients. Considering ISH for EBER detection results: - 1 out 2 (50%) adult analyzed cases was positive, with 50% of stained tumor cells (this patient was a 22 years old female, coming from Napoli); - 15 out 24 (62.5%) children analyzed Burkitt's lymphomas resulted as positive for EBER; - the overall positivity has been observed in 16/26 Burkitt's lymphomas (61.53%). - Finally, EBV has been detected in children and adult patients, one of them with deregulation of the oncogene c-MYC by chromosomal translocation. The exact worldwide incidence of Burkitt's lymphoma is not known. There are three distinct clinical variants of Burkitt's lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt's lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt's lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt's lymphomas occurs in children (age range 3-12), and 8 were adulthood Burkitt's lymphomas (age range 18-87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients. Considering ISH for EBER detection results: 1 out 2 (50%) adult analyzed cases was positive, with 50% of stained tumor cells (this patient was a 22 years old female, coming from Napoli);15 out 24 (62.5%) children analyzed Burkitt's lymphomas resulted as positive for EBER;the overall positivity has been observed in 16/26 Burkitt's lymphomas (61.53%).Finally, EBV has been detected in children and adult patients, one of them with deregulation of the oncogene c-MYC by chromosomal translocation.The exact worldwide incidence of Burkitt's lymphoma is not known. There are three distinct clinical variants of Burkitt's lymphoma, each manifesting differences in epidemiology, clinical presentation, morphology, biology and genetic features: the endemic (African), the sporadic (non-endemic), and the immunodeficiency-associated form. In particular, we reported data regarding Burkitt's lymphoma incidence in the world and across different European countries. Finally, we described clinic-pathological data of 48 Burkitt's lymphomas occurred in Italy from 2003 to 2013, in 4 different hospitals, two of which located in east side, and the other ones located in the west-coast. Forty Burkitt's lymphomas occurs in children (age range 3-12), and 8 were adulthood Burkitt's lymphomas (age range 18-87). In the pediatric group the Male:Female ratio (M:F) was of 4:1, whereas the group of the adult patients has a M:F of 1:1.67. Immunohistochemical detection of Latent Membrane Protein 1 (LMP1) expression and Epstein-Barr virus Encoded RNA (EBER) In Situ Hybridization (ISH) procedures have been performed. Lymphocyte B monoclonal spread has been demonstrated using a Polymerase Chain Reaction (PCR) based method to amplify Fragment Restriction FR1, FR2 and FR3 immunoglobulin heavy chains DNA fragments. Only 38 cases out of 48 were analyzed for LMP-1 showing various percentage of stained cells in 47.4% of the patients. Considering ISH for EBER detection results: 1 out 2 (50%) adult analyzed cases was positive, with 50% of stained tumor cells (this patient was a 22 years old female, coming from Napoli);15 out 24 (62.5%) children analyzed Burkitt's lymphomas resulted as positive for EBER;the overall positivity has been observed in 16/26 Burkitt's lymphomas (61.53%).Finally, EBV has been detected in children and adult patients, one of them with deregulation of the oncogene c-MYC by chromosomal translocation. |
| ArticleNumber | 34 |
| Audience | Academic |
| Author | Errico, Maria Elena Pannone, Giuseppe Aquino, Gabriella Zamparese, Rosanna Cagiano, Simona Bucci, Eduardo Franco, Renato De Chiara, Annarosaria Santoro, Angela Bufo, Pantaleo Pedicillo, Maria Carmela Bucci, Paolo Somma, Pasquale Pace, Mirella Donofrio, Vittoria |
| Author_xml | – sequence: 1 givenname: Giuseppe surname: Pannone fullname: Pannone, Giuseppe organization: Department of Clinical and Experimental Medicine, Institute of Pathological Anatomy, University of Foggia – sequence: 2 givenname: Rosanna surname: Zamparese fullname: Zamparese, Rosanna organization: Section of Pathological Anatomy Ospedale di Ascoli – sequence: 3 givenname: Mirella surname: Pace fullname: Pace, Mirella organization: Department of Clinical and Experimental Medicine, Institute of Pathological Anatomy, University of Foggia – sequence: 4 givenname: Maria Carmela surname: Pedicillo fullname: Pedicillo, Maria Carmela organization: Department of Clinical and Experimental Medicine, Institute of Pathological Anatomy, University of Foggia – sequence: 5 givenname: Simona surname: Cagiano fullname: Cagiano, Simona organization: Department of Clinical and Experimental Medicine, Institute of Pathological Anatomy, University of Foggia – sequence: 6 givenname: Pasquale surname: Somma fullname: Somma, Pasquale organization: Section of Pathological Anatomy, Ospedale dei Colli - Monaldi – sequence: 7 givenname: Maria Elena surname: Errico fullname: Errico, Maria Elena organization: Section of Pathological Anatomy, Paediatric Oncological Hospital Pausillipon – sequence: 8 givenname: Vittoria surname: Donofrio fullname: Donofrio, Vittoria organization: Section of Pathological Anatomy, Paediatric Oncological Hospital Pausillipon – sequence: 9 givenname: Renato surname: Franco fullname: Franco, Renato organization: Pathology Unit - Istituto Nazionale dei Tumori – sequence: 10 givenname: Annarosaria surname: De Chiara fullname: De Chiara, Annarosaria organization: Pathology Unit - Istituto Nazionale dei Tumori – sequence: 11 givenname: Gabriella surname: Aquino fullname: Aquino, Gabriella organization: Pathology Unit - Istituto Nazionale dei Tumori – sequence: 12 givenname: Paolo surname: Bucci fullname: Bucci, Paolo organization: Department of Odontostomatological and Maxillofacial Sciences, University of Napoli 'Federico II' – sequence: 13 givenname: Eduardo surname: Bucci fullname: Bucci, Eduardo organization: Department of Odontostomatological and Maxillofacial Sciences, University of Napoli 'Federico II' – sequence: 14 givenname: Angela surname: Santoro fullname: Santoro, Angela email: angelasantoro1@hotmail.it organization: Department of Laboratory, Institute of Histopathology and Diagnostic Cytopathology, Fondazione di Ricerca e Cura 'Giovanni Paolo II'-UCSC, Piazza Attilio Omodei Zorini – sequence: 15 givenname: Pantaleo surname: Bufo fullname: Bufo, Pantaleo organization: Department of Clinical and Experimental Medicine, Institute of Pathological Anatomy, University of Foggia, IRCCS CROB - Basilicata Cancer Institute |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25364378$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks1u1DAUhS1URNuBLUtkiU03aeO_OGGB1FYFKo3EprBDluPczLgkdrCTSrPjNXg9ngRHLdNpVSTkha17v3NkH99DtOe8A4Rek_yYkLI4IVLkWcVkmVUZ48_Qwbawt3PeR4cxXuc5L2lZvkD7VLCCp_oB-na1Bhx8B9i3-OLsK7YOj6k06HHtV-Ag2ji3zqbw3Y7j75-_Il5u-mHte_0Oa4cvR93ZtK99HGw641pHaHCcwg1sXqLnre4ivLrbF-jLh4ur80_Z8vPHy_PTZWaE4GNGSV3LqinbhjaaVrluiS5EI4DSRhpa68ZAQTipq5aISpdSGuDMaMlywVkDbIHe3_oOU91Dot0YdKeGYHsdNsprqx52nF2rlb9RnJKCCZYMju4Mgv8xQRxVb6OBrtMO_BQVKQQvpKQ5_Q-U5gnjpUjo20fotZ-CS0kkishKFpLLe2qlO1DWtT5d0cym6lTwvBCUpVcu0PETVFoN9NakoWhtqj8QvNnNZBvG37-_dzTBxxig3SIkV_NwqXl-1Dw_qlJsduSPBCb9-Gj9nKnt_i07uZXF5O9WEHZSeFrxB_0o39g |
| CitedBy_id | crossref_primary_10_5933_JKAPD_2016_43_4_452 crossref_primary_10_3389_fimmu_2021_761798 crossref_primary_10_1093_tropej_fmw082 crossref_primary_10_3389_fimmu_2024_1297994 crossref_primary_10_3390_cancers13215534 crossref_primary_10_3390_ijms22041956 crossref_primary_10_1016_j_critrevonc_2021_103289 crossref_primary_10_3390_genes12091302 crossref_primary_10_1186_s13027_022_00452_0 crossref_primary_10_1080_13696998_2024_2350877 crossref_primary_10_3389_fmicb_2014_00655 crossref_primary_10_3390_jcm6120111 crossref_primary_10_7759_cureus_26860 crossref_primary_10_3390_biology10060533 crossref_primary_10_3389_fcimb_2022_935205 crossref_primary_10_1016_j_radcr_2022_11_076 crossref_primary_10_1111_bjh_13925 crossref_primary_10_3390_cancers14030480 crossref_primary_10_1080_20009666_2019_1574545 crossref_primary_10_1177_0961203317753069 crossref_primary_10_1016_j_blre_2024_101172 crossref_primary_10_1038_s41598_018_37070_z crossref_primary_10_1186_s12860_019_0219_y crossref_primary_10_1097_MPH_0000000000001635 crossref_primary_10_1016_j_ijmmb_2022_03_008 crossref_primary_10_1182_bloodadvances_2022007695 crossref_primary_10_1007_s11033_021_06152_z crossref_primary_10_1177_10406387231155414 crossref_primary_10_1021_acs_molpharmaceut_2c01080 crossref_primary_10_18632_aging_204345 crossref_primary_10_1073_pnas_2314426121 crossref_primary_10_1016_j_bbcan_2024_189218 crossref_primary_10_3389_fonc_2023_1175545 crossref_primary_10_1007_s12026_015_8777_3 |
| Cites_doi | 10.1182/blood-2010-05-282632 10.1016/j.ejca.2004.09.004 10.1097/01.MP.0000019577.73786.64 10.1309/MMAU-0QYH-7BHA-W8C2 10.1007/978-3-642-67236-1_4 10.1097/00043426-199122000-00019 10.3748/wjg.14.4347 10.1038/35095584 10.1126/science.6401867 10.1136/mp.53.5.248 10.1136/bmj.2.5311.1019 10.1038/nm758 10.1002/rmv.1980040404 10.1016/0167-5699(85)90036-2 10.1034/j.1399-0012.2000.140406.x 10.1038/leu.2011.156 10.1073/pnas.83.9.2984 10.1182/blood-2010-03-275917 10.1200/JCO.1996.14.3.925 10.1016/S1368-8375(97)00041-9 10.1111/j.1365-2141.2011.09013.x 10.1200/JCO.1996.14.4.1252 10.1097/01.pas.0000168176.71405.e5 10.1001/archinte.163.17.1997 10.1182/blood-2005-06-2508 10.1200/JCO.2000.18.21.3707 10.1182/blood.V97.11.3370 10.4049/jimmunol.1102277 10.1016/S1525-1578(10)60642-3 10.1038/ng.2468 10.1016/S0065-230X(08)60712-5 10.1182/blood.V91.4.1373 10.1182/blood.V86.2.659.bloodjournal862659 10.1128/mr.59.3.387-405.1995 10.1309/8WYNVUTGV9RPHUQH 10.1111/j.1399-0012.2012.01608.x 10.1016/S1074-7613(00)80493-8 10.1182/blood-2004-02-0405 10.4161/cc.9.5.10840 10.1002/path.1711750303 10.1038/274756a0 10.1126/science.6356357 |
| ContentType | Journal Article |
| Copyright | Pannone et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. COPYRIGHT 2014 BioMed Central Ltd. 2014 Pannone et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. Pannone et al.; licensee BioMed Central Ltd. 2014 |
| Copyright_xml | – notice: Pannone et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. – notice: COPYRIGHT 2014 BioMed Central Ltd. – notice: 2014 Pannone et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. – notice: Pannone et al.; licensee BioMed Central Ltd. 2014 |
| DBID | C6C AAYXX CITATION NPM 3V. 7TO 7U9 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1186/1750-9378-9-34 |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts PubMed CrossRef Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1750-9378 |
| EndPage | 34 |
| ExternalDocumentID | PMC4216353 3474755651 A540652354 25364378 10_1186_1750_9378_9_34 |
| Genre | Journal Article Review |
| GeographicLocations | Northern Africa |
| GeographicLocations_xml | – name: Northern Africa |
| GroupedDBID | --- 0R~ 29I 2WC 4.4 53G 5GY 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ITC KQ8 M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PUEGO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW ~8M AAYXX ALIPV CITATION 2VQ C1A IPNFZ NPM RIG PMFND 3V. 7TO 7U9 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c554t-21bb79d8fd2da290af1a65d5e22d7c2badce6141b9f159a877ce43ca730543de3 |
| IEDL.DBID | M48 |
| ISSN | 1750-9378 |
| IngestDate | Thu Aug 21 18:17:42 EDT 2025 Fri Sep 05 04:38:32 EDT 2025 Fri Sep 05 05:04:48 EDT 2025 Mon Jun 30 06:59:06 EDT 2025 Tue Jun 17 22:05:44 EDT 2025 Tue Jun 10 21:11:31 EDT 2025 Mon Jul 21 05:55:39 EDT 2025 Tue Jul 01 02:03:56 EDT 2025 Thu Apr 24 22:53:15 EDT 2025 Sat Sep 06 07:29:06 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Burkitt’s lymphoma Immunohistochemistry In situ hybridization |
| Language | English |
| License | This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c554t-21bb79d8fd2da290af1a65d5e22d7c2badce6141b9f159a877ce43ca730543de3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1750-9378-9-34 |
| PMID | 25364378 |
| PQID | 1617976747 |
| PQPubID | 54871 |
| PageCount | 1 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4216353 proquest_miscellaneous_1654677202 proquest_miscellaneous_1620023485 proquest_journals_1617976747 gale_infotracmisc_A540652354 gale_infotracacademiconefile_A540652354 pubmed_primary_25364378 crossref_primary_10_1186_1750_9378_9_34 crossref_citationtrail_10_1186_1750_9378_9_34 springer_journals_10_1186_1750_9378_9_34 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-10-15 |
| PublicationDateYYYYMMDD | 2014-10-15 |
| PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Infectious agents and cancer |
| PublicationTitleAbbrev | Infect Agents Cancer |
| PublicationTitleAlternate | Infect Agent Cancer |
| PublicationYear | 2014 |
| Publisher | BioMed Central BioMed Central Ltd |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd |
| References | CJ Holman (505_CR8) 2012; 26 G de Thé (505_CR5) 1978; 274 DH Wright (505_CR4) 1971; 6 G Klein (505_CR39) 1985; 6 Q Tao (505_CR3) 1998; 91 D Lenze (505_CR52) 2011; 25 ML Gulley (505_CR53) 2002; 117 C Love (505_CR43) 2012; 44 J Diebold (505_CR44) 2001 G Kelly (505_CR17) 2002; 8 H Sousa (505_CR12) 2008K; 14 EG Boerma (505_CR26) 2004; 40 M Guech-Ongey (505_CR28) 2010; 116 IT Magrath (505_CR35) 1991; 13 WP Bowman (505_CR47) 1996; 14 ML Gulley (505_CR56) 2001; 3 AH Cardy (505_CR30) 2001; 33 M Frost (505_CR51) 2004; 121 N Nakamura (505_CR49) 2002; 15 KT Bieging (505_CR20) 2010; 9 DP Burkitt (505_CR31) 1962; 2 G Niedobitek (505_CR18) 1995; 86 SH Swerdlow (505_CR25) 2008 LM Morton (505_CR23) 2006; 107 E Haralambieva (505_CR50) 2005; 29 I Magrath (505_CR21) 2012; 156 R Khanna (505_CR33) 1995; 59 M Sant (505_CR24) 2010; 116 EME MacMahon (505_CR55) 1994; 4 P Andreone (505_CR7) 2003; 163 KA Blum (505_CR45) 2004; 104 GG Dalla-Favera (505_CR42) 1995; 67 DH Crawford (505_CR6) 2001 G Brady (505_CR19) 2007; 60 AB Rickinson (505_CR34) 1996 S Ocheni (505_CR2) 2010; 4 I Magrath (505_CR48) 1996; 14 C Merlino (505_CR9) 2003; 26 M Raphael (505_CR29) 1991; 115 M Hummel (505_CR36) 1995; 175 DA Thorley-Lawson (505_CR15) 2001; 1 IT Magrath (505_CR27) 1985; 60 P Leder (505_CR38) 1983; 222 C Patte (505_CR46) 2001; 97 T Orii (505_CR10) 2000; 14 S Durand-Panteix (505_CR1) 2012; 189 P Pelicci (505_CR41) 1986; 83 JL Hecht (505_CR13) 2000; 18 DP Burkitt (505_CR32) 1989 J Shapira (505_CR37) 1998; 34 W Henle (505_CR16) 1979 DH Wright (505_CR14) 1967; 27 R Dalla-Favera (505_CR40) 1983; 219 G Khan (505_CR54) 1996; 5 G Niedobitek (505_CR11) 2000; 53 DP Burkitt (505_CR22) 1963; 40 6401867 - Science. 1983 Feb 25;219(4587):963-7 11054444 - J Clin Oncol. 2000 Nov 1;18(21):3707-21 4295479 - Cancer Res. 1967 Dec;27(12):2424-38 2069232 - Am J Pediatr Hematol Oncol. 1991 Summer;13(2):222-46 12219084 - Nat Med. 2002 Oct;8(10):1098-104 22385033 - Clin Transplant. 2012 Sep-Oct;26(5):741-7 6356357 - Science. 1983 Nov 18;222(4625):765-71 8571813 - Adv Cancer Res. 1995;67:113-53 22260300 - Br J Haematol. 2012 Mar;156(6):744-56 7565411 - Microbiol Rev. 1995 Sep;59(3):387-405 12737195 - New Microbiol. 2003 Apr;26(2):141-9 2998986 - IARC Sci Publ. 1985;(60):119-27 4342309 - Pathol Annu. 1971;6:337-63 21701491 - Leukemia. 2011 Dec;25(12):1869-76 8648381 - J Clin Oncol. 1996 Apr;14(4):1252-61 23143597 - Nat Genet. 2012 Dec;44(12):1321-5 9659515 - Oral Oncol. 1998 Jan;34(1):15-23 210392 - Nature. 1978 Aug 24;274(5673):756-61 15265787 - Blood. 2004 Nov 15;104(10):3009-20 8769480 - Immunity. 1996 Aug;5(2):173-9 25290182 - Immunol Today. 1985 Jul;6(7):208-15 8622041 - J Clin Oncol. 1996 Mar;14(3):925-34 14504111 - Arch Intern Med. 2003 Sep 22;163(17):1997-2004 11905817 - Nat Rev Immunol. 2001 Oct;1(1):75-82 11369626 - Blood. 2001 Jun 1;97(11):3370-9 16006805 - Am J Surg Pathol. 2005 Aug;29(8):1086-94 11091848 - Mol Pathol. 2000 Oct;53(5):248-54 20664057 - Blood. 2010 Nov 11;116(19):3724-34 20160479 - Cell Cycle. 2010 Mar 1;9(5):901-8 15571961 - Eur J Cancer. 2004 Dec;40(18):2781-7 14017064 - Br Med J. 1962 Oct 20;2(5311):1019-23 12118116 - Mod Pathol. 2002 Jul;15(7):771-6 14017065 - East Afr Med J. 1963 Jan;40:1-6 22661084 - J Immunol. 2012 Jul 1;189(1):181-90 3458257 - Proc Natl Acad Sci U S A. 1986 May;83(9):2984-8 9454768 - Blood. 1998 Feb 15;91(4):1373-81 11313005 - Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):461-73 18666324 - World J Gastroenterol. 2008 Jul 21;14(27):4347-51 20813897 - Blood. 2010 Dec 16;116(25):5600-4 11227065 - J Mol Diagn. 2001 Feb;3(1):1-10 1987908 - Arch Pathol Lab Med. 1991 Jan;115(1):15-20 7605996 - Blood. 1995 Jul 15;86(2):659-65 16150940 - Blood. 2006 Jan 1;107(1):265-76 15023043 - Am J Clin Pathol. 2004 Mar;121(3):384-92 11863222 - Am J Clin Pathol. 2002 Feb;117(2):259-67 10945201 - Clin Transplant. 2000 Aug;14(4 Pt 1):308-17 7745495 - J Pathol. 1995 Mar;175(3):263-71 18042696 - J Clin Pathol. 2007 Dec;60(12):1397-402 |
| References_xml | – volume: 116 start-page: 3724 year: 2010 ident: 505_CR24 publication-title: Blood doi: 10.1182/blood-2010-05-282632 – volume: 40 start-page: 2781 year: 2004 ident: 505_CR26 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2004.09.004 – volume: 60 start-page: 1397 year: 2007 ident: 505_CR19 publication-title: J Clin Pathol – volume: 15 start-page: 771 year: 2002 ident: 505_CR49 publication-title: Mod Pathol doi: 10.1097/01.MP.0000019577.73786.64 – volume: 117 start-page: 259 year: 2002 ident: 505_CR53 publication-title: Am J Clin Pathol doi: 10.1309/MMAU-0QYH-7BHA-W8C2 – start-page: 61 volume-title: The Epstein-Barr Virus year: 1979 ident: 505_CR16 doi: 10.1007/978-3-642-67236-1_4 – volume: 13 start-page: 222 year: 1991 ident: 505_CR35 publication-title: Am J Pediatr Hematol Oncol doi: 10.1097/00043426-199122000-00019 – volume: 14 start-page: 4347 year: 2008K ident: 505_CR12 publication-title: World J Gastroenterol doi: 10.3748/wjg.14.4347 – volume: 1 start-page: 75 year: 2001 ident: 505_CR15 publication-title: Nat Rev Immunol doi: 10.1038/35095584 – volume: 219 start-page: 963 year: 1983 ident: 505_CR40 publication-title: Science doi: 10.1126/science.6401867 – volume: 115 start-page: 15 year: 1991 ident: 505_CR29 publication-title: Arch Pathol Lab Med – volume: 53 start-page: 248 year: 2000 ident: 505_CR11 publication-title: J Clin Pathol Mol Pathol doi: 10.1136/mp.53.5.248 – volume: 2 start-page: 1019 year: 1962 ident: 505_CR31 publication-title: Br Med J doi: 10.1136/bmj.2.5311.1019 – volume: 8 start-page: 1098 year: 2002 ident: 505_CR17 publication-title: Nat Med doi: 10.1038/nm758 – volume: 4 start-page: 251 year: 1994 ident: 505_CR55 publication-title: Rev Med Virol doi: 10.1002/rmv.1980040404 – volume: 6 start-page: 208 year: 1985 ident: 505_CR39 publication-title: Immunol Today doi: 10.1016/0167-5699(85)90036-2 – volume: 27 start-page: 2424 year: 1967 ident: 505_CR14 publication-title: Cancer Res – volume: 14 start-page: 308 issue: 4 Pt 1 year: 2000 ident: 505_CR10 publication-title: Clin Transplant doi: 10.1034/j.1399-0012.2000.140406.x – volume: 25 start-page: 1869 year: 2011 ident: 505_CR52 publication-title: Leukemia doi: 10.1038/leu.2011.156 – volume: 26 start-page: 141 year: 2003 ident: 505_CR9 publication-title: New Microbiol – volume: 83 start-page: 2984 year: 1986 ident: 505_CR41 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.83.9.2984 – volume: 116 start-page: 5600 year: 2010 ident: 505_CR28 publication-title: Blood doi: 10.1182/blood-2010-03-275917 – volume: 14 start-page: 925 year: 1996 ident: 505_CR48 publication-title: J Clin Oncol doi: 10.1200/JCO.1996.14.3.925 – volume: 34 start-page: 15 year: 1998 ident: 505_CR37 publication-title: Oral Oncol doi: 10.1016/S1368-8375(97)00041-9 – volume: 156 start-page: 744 issue: 6 year: 2012 ident: 505_CR21 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2011.09013.x – volume: 40 start-page: 1 year: 1963 ident: 505_CR22 publication-title: East Afr Med J – volume: 14 start-page: 1252 year: 1996 ident: 505_CR47 publication-title: J Clin Oncol doi: 10.1200/JCO.1996.14.4.1252 – volume: 29 start-page: 1086 year: 2005 ident: 505_CR50 publication-title: Am J Surg Pathol doi: 10.1097/01.pas.0000168176.71405.e5 – volume: 163 start-page: 1997 year: 2003 ident: 505_CR7 publication-title: Arch Intern Med doi: 10.1001/archinte.163.17.1997 – volume: 107 start-page: 265 year: 2006 ident: 505_CR23 publication-title: Blood doi: 10.1182/blood-2005-06-2508 – volume: 18 start-page: 3707 year: 2000 ident: 505_CR13 publication-title: J Clin Oncol doi: 10.1200/JCO.2000.18.21.3707 – volume: 97 start-page: 3370 year: 2001 ident: 505_CR46 publication-title: Blood doi: 10.1182/blood.V97.11.3370 – volume: 189 start-page: 181 year: 2012 ident: 505_CR1 publication-title: J Immunol doi: 10.4049/jimmunol.1102277 – start-page: 356461 volume-title: Philos Trans R Soc Lond B Biol Sci year: 2001 ident: 505_CR6 – volume: 3 start-page: 1 issue: 1 year: 2001 ident: 505_CR56 publication-title: J Mol Diagn doi: 10.1016/S1525-1578(10)60642-3 – volume: 44 start-page: 1321 issue: 12 year: 2012 ident: 505_CR43 publication-title: Nat Genet doi: 10.1038/ng.2468 – volume: 33 start-page: 293 issue: 4 year: 2001 ident: 505_CR30 publication-title: Kuwait Med J – volume: 67 start-page: 113 year: 1995 ident: 505_CR42 publication-title: Adv Cancer Res doi: 10.1016/S0065-230X(08)60712-5 – volume: 6 start-page: 337 year: 1971 ident: 505_CR4 publication-title: Pathol Annu – volume: 91 start-page: 1373 issue: 4 year: 1998 ident: 505_CR3 publication-title: Blood doi: 10.1182/blood.V91.4.1373 – volume: 86 start-page: 659 year: 1995 ident: 505_CR18 publication-title: Blood doi: 10.1182/blood.V86.2.659.bloodjournal862659 – volume: 59 start-page: 387 year: 1995 ident: 505_CR33 publication-title: Microbiol Rev doi: 10.1128/mr.59.3.387-405.1995 – volume: 121 start-page: 384 year: 2004 ident: 505_CR51 publication-title: Am J Clin Pathol doi: 10.1309/8WYNVUTGV9RPHUQH – start-page: 2397 volume-title: Field’s Virology year: 1996 ident: 505_CR34 – volume: 4 start-page: 101 year: 2010 ident: 505_CR2 publication-title: The Open Infectious Dis J – volume: 26 start-page: 741 year: 2012 ident: 505_CR8 publication-title: Clin Transplant doi: 10.1111/j.1399-0012.2012.01608.x – start-page: 181 volume-title: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues year: 2001 ident: 505_CR44 – volume: 5 start-page: 173 year: 1996 ident: 505_CR54 publication-title: Immunity doi: 10.1016/S1074-7613(00)80493-8 – volume: 60 start-page: 119 year: 1985 ident: 505_CR27 publication-title: IARC Sci Publ – volume: 104 start-page: 3009 year: 2004 ident: 505_CR45 publication-title: Blood doi: 10.1182/blood-2004-02-0405 – volume: 9 start-page: 901 issue: 5 year: 2010 ident: 505_CR20 publication-title: Cell Cycle doi: 10.4161/cc.9.5.10840 – volume: 175 start-page: 263 year: 1995 ident: 505_CR36 publication-title: J Pathol doi: 10.1002/path.1711750303 – volume: 274 start-page: 756 issue: 5673 year: 1978 ident: 505_CR5 publication-title: Nature doi: 10.1038/274756a0 – volume-title: Epstein-Barr Virus and Human Disease year: 1989 ident: 505_CR32 – volume-title: World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues year: 2008 ident: 505_CR25 – volume: 222 start-page: 765 year: 1983 ident: 505_CR38 publication-title: Science doi: 10.1126/science.6356357 – reference: 22661084 - J Immunol. 2012 Jul 1;189(1):181-90 – reference: 2998986 - IARC Sci Publ. 1985;(60):119-27 – reference: 8571813 - Adv Cancer Res. 1995;67:113-53 – reference: 7605996 - Blood. 1995 Jul 15;86(2):659-65 – reference: 7565411 - Microbiol Rev. 1995 Sep;59(3):387-405 – reference: 14017065 - East Afr Med J. 1963 Jan;40:1-6 – reference: 25290182 - Immunol Today. 1985 Jul;6(7):208-15 – reference: 14504111 - Arch Intern Med. 2003 Sep 22;163(17):1997-2004 – reference: 22260300 - Br J Haematol. 2012 Mar;156(6):744-56 – reference: 11227065 - J Mol Diagn. 2001 Feb;3(1):1-10 – reference: 9454768 - Blood. 1998 Feb 15;91(4):1373-81 – reference: 12118116 - Mod Pathol. 2002 Jul;15(7):771-6 – reference: 11905817 - Nat Rev Immunol. 2001 Oct;1(1):75-82 – reference: 1987908 - Arch Pathol Lab Med. 1991 Jan;115(1):15-20 – reference: 10945201 - Clin Transplant. 2000 Aug;14(4 Pt 1):308-17 – reference: 11091848 - Mol Pathol. 2000 Oct;53(5):248-54 – reference: 7745495 - J Pathol. 1995 Mar;175(3):263-71 – reference: 6356357 - Science. 1983 Nov 18;222(4625):765-71 – reference: 210392 - Nature. 1978 Aug 24;274(5673):756-61 – reference: 4342309 - Pathol Annu. 1971;6:337-63 – reference: 8622041 - J Clin Oncol. 1996 Mar;14(3):925-34 – reference: 2069232 - Am J Pediatr Hematol Oncol. 1991 Summer;13(2):222-46 – reference: 12219084 - Nat Med. 2002 Oct;8(10):1098-104 – reference: 11863222 - Am J Clin Pathol. 2002 Feb;117(2):259-67 – reference: 8769480 - Immunity. 1996 Aug;5(2):173-9 – reference: 15265787 - Blood. 2004 Nov 15;104(10):3009-20 – reference: 3458257 - Proc Natl Acad Sci U S A. 1986 May;83(9):2984-8 – reference: 15023043 - Am J Clin Pathol. 2004 Mar;121(3):384-92 – reference: 22385033 - Clin Transplant. 2012 Sep-Oct;26(5):741-7 – reference: 11313005 - Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):461-73 – reference: 11369626 - Blood. 2001 Jun 1;97(11):3370-9 – reference: 20160479 - Cell Cycle. 2010 Mar 1;9(5):901-8 – reference: 18666324 - World J Gastroenterol. 2008 Jul 21;14(27):4347-51 – reference: 15571961 - Eur J Cancer. 2004 Dec;40(18):2781-7 – reference: 14017064 - Br Med J. 1962 Oct 20;2(5311):1019-23 – reference: 23143597 - Nat Genet. 2012 Dec;44(12):1321-5 – reference: 16006805 - Am J Surg Pathol. 2005 Aug;29(8):1086-94 – reference: 20664057 - Blood. 2010 Nov 11;116(19):3724-34 – reference: 16150940 - Blood. 2006 Jan 1;107(1):265-76 – reference: 8648381 - J Clin Oncol. 1996 Apr;14(4):1252-61 – reference: 18042696 - J Clin Pathol. 2007 Dec;60(12):1397-402 – reference: 4295479 - Cancer Res. 1967 Dec;27(12):2424-38 – reference: 11054444 - J Clin Oncol. 2000 Nov 1;18(21):3707-21 – reference: 21701491 - Leukemia. 2011 Dec;25(12):1869-76 – reference: 12737195 - New Microbiol. 2003 Apr;26(2):141-9 – reference: 6401867 - Science. 1983 Feb 25;219(4587):963-7 – reference: 9659515 - Oral Oncol. 1998 Jan;34(1):15-23 – reference: 20813897 - Blood. 2010 Dec 16;116(25):5600-4 |
| SSID | ssj0048288 |
| Score | 2.171512 |
| SecondaryResourceType | review_article |
| Snippet | The exact worldwide incidence of Burkitt’s lymphoma is not known. There are three distinct clinical variants of Burkitt’s lymphoma, each manifesting... The exact worldwide incidence of Burkitt's lymphoma is not known. There are three distinct clinical variants of Burkitt's lymphoma, each manifesting... Doc number: 34 Abstract: The exact worldwide incidence of Burkitt's lymphoma is not known. There are three distinct clinical variants of Burkitt's lymphoma,... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 34 |
| SubjectTerms | Biomedical and Life Sciences Biomedicine Cancer Research Clinical oncology Epidemiology Epstein-Barr virus Gene expression HIV Human immunodeficiency virus Immunohistochemistry Infections Infectious Diseases Lymphoma Oncology Pathogenesis Patients Physiological aspects Review Studies Surveys Tropical Medicine Tumors |
| SummonAdditionalLinks | – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIhLxZtAQUZCKheriR9xwgW1qFVBlBNFK3GwHNtpV0DSbrJI_ffMZL2hWUHPnli2x-PvG3syQ8ibsgQOUHvJnHOSSQ0mZWvtWe5SbzOgdHyo1nDyJT8-lZ9mahYv3LoYVrk-E4eD2rcO78j3kIeXmHlGv7-4ZFg1Cl9XYwmN2-ROBkwESzfo2ehwSfAmipioMSvyPUDKlAEcg4UzISdAtHkcX8OjzVjJjQfTAYeO7pPtSCDp_krjD8it0Dwkd0_iE_kj8h0UTzFmkLY1PTz4RucNBZJHsfRwe4Yn27zDpoPl4se873c7-vkKNNr-su-obejHfrj4oOexnghFmPO0Wy5-h6vH5PTo8OuHYxYrKDAHNKFnPKsqXfqi9txbXqa2zmyuvAqce-14ZWFagM9ZVdZAa2yhtQtSOAtmr6TwQTwhW03bhGeE1uDLAvTnhcZrIy0sEIk6DWlZQO-Opwlh6-U0LqYXxyoXP83gZhS5weU3uPymNEImZHeUv1gl1vi_JGrHoMVBj87GHwdgXJi7yuwD6czBn1YguTORBEtx0-a1fk201M783VcJeT0245cYfdaEdokyGMoiZKFuklGAOZqnPCFPV1tmnBdXAt9Hi4ToyWYaBTDH97SlmZ8Pub4lB8KsRELerrfdtaH_c7me3zzLF-QecD6J8JupHbLVL5bhJfCqvno1GM8fPfofIQ priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagSIhLxZtAQUZCgotF4kfscGtXrQqinCjqBVmO7dAVNEG7WaTe-Bv8PX4JM1nvarM8xNnjKPF4_H2TGc8Q8qyqgAM0QTLvvWRSg0m5RgdW-jy4AigdH7o1nLwrj0_lmzN1lhJk8S7MZvy-MOVLQLecAYSCVTIhr5JrCg5d3MmTcrI6cSV4DSYVZPx9zghwto_dDdzZzoncCowOeHN0k-wmokj3l5q9Ra7E9ja5fpJC4XfIR1AwxdxA2jX08OADnbYUyBzFFsPdJzzBpnMcOljMPk_7_uf3H3P69hJ01124V9S19HU__OKg56lzCEVAC3S-mH2Ll3fJ6dHh-8kxS70SmAdC0DNe1LWugmkCD45XuWsKV6qgIudBe147-DBA4qKuGiAwzmjtoxTegYErKUIU98hO27XxAaENeK0A8qXR-INICweUocljXhl4uud5RthqQa1PhcSxn8UXOzgUprSoAIsKsJUVMiPP1_JflyU0_i6J-rFoW_BE79IVAXgvrFJl94FeluA5K5DcG0mCTfjx8ErDNtnk3KInV2HtIp2Rp-thnIl5Zm3sFiiDSStCGvUvGQXoonnOM3J_uWnW38WVwEioyYgebae1AFbzHo-00_OhqrfkQI2VyMiL1cbbePU_LtfD_xd9RG4A05MIuoXaIzv9bBEfA5vq6yeDKf0CyoYXwg priority: 102 providerName: Springer Nature |
| Title | The role of EBV in the pathogenesis of Burkitt’s Lymphoma: an Italian hospital based survey |
| URI | https://link.springer.com/article/10.1186/1750-9378-9-34 https://www.ncbi.nlm.nih.gov/pubmed/25364378 https://www.proquest.com/docview/1617976747 https://www.proquest.com/docview/1620023485 https://www.proquest.com/docview/1654677202 https://pubmed.ncbi.nlm.nih.gov/PMC4216353 |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fi9NAEB-8OxBfxP9Gz7KCoC_RZLObTQSRtvQ4i3eIWumLhM1u4hXPRNtU7Jtfw6_nJ3EmTeK1nj74FMhO_u3M7PxmZzID8CCOEQPkVrjGGOEKhSqlc2Xd0HhW-wjpeN2t4eg4PJyI8VROf-c_NRO4ONe1o35Sk_np429fVs9R4Z_VCh-FT9ACei6aWdRcNxA7sFfHiiiNT3QRBYGeRdQUbfzzGioJLAOKYUUb9ml7lT5jprZTKLfiqLV5OrgClxtcyfprQbgKF7LiGlw8aiLn1-E9ygOjVEJW5mw0eMdmBUPsx6gjcfmBFrzZgoYGy_nHWVX9_P5jwV6ukNXlJ_2U6YK9qOodEXbSNBphZP8sWyznX7PVDZgcjN4OD92mtYJrED9ULvfTVMU2yi23mseezn0dSiszzq0yPNX4YWi4_TTOEe_oSCmTicBoXA-kCGwW3ITdoiyy28BydHIRE4SRov0kFWhEGLmXeXGEdzfcc8BtJzQxTd1xan9xmtT-RxQmxIuEeJHESSAceNjRf15X3Pg7JfEnIeHAOxrd_FGA70VFrZI-otEQHW2JlPsblKhCZnO45XDSSmBCjl9MpY6UA_e7YbqS0tKKrFwSDeW4BCKS_6KRaIwU97gDt9ZC031XK3QOqA1x6gio-PfmSDE7qYuAC45IWgYOPGoF78yrnztdd_77IXfhEuJEQSbbl_uwW82X2T3EYlXagx01VT3Y6_fHb8Z4HIyOX73Gs8Nw2Kv3N3q1Gv4CQGM2PA |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJ8FeEN8EBhgJNF6iJY4TJ0gTWqFTy9oKoQ1N4sG4trNVQDLaFNR_jr-Nu9QpawV727MvlnO-8-93_rgj5EWWAQfIDfe11tznAlxK5cL4iQ6MCoHSsbpaw2CYdI_5-5P4ZIP8bt7C4LXKZk2sF2pTatwj30UenmHmGfHm_IePVaPwdLUpoaFcaQWzV6cYcw87Du38F4Rw073eO5jvl4wddI7edn1XZcDXAKWVz8LRSGQmzQ0zimWBykOVxCa2jBmh2UgZbQHDwlGWA_SrVAhteaQVuEbMI2Mj6Pca2eS4gdIim-3O8MPHBgs4xDOpSxUZpskuYHXgAyGANcaP-AoUrgPCBURcv625dmRbI-HBLXLTUVi6v7C522TDFnfI9YE7pL9LPoPpUby1SMucdtqf6LigQDMpFj8uT3FtHU-xqT2bfB1X1c6U9udgU-V39ZqqgvaqeuuFnrmKJhSB1tDpbPLTzu-R4yvR7n3SKsrCPiQ0h2gayEeSCty4EpECKpMHNshS6F2zwCN-o06pXYJzrLPxTdaBTppIVL9E9ctMRtwjO0v580Vqj_9L4uxI9HnoUSv3dAHGhdmz5D5MfQIRfQyS2yuS4Kt6tbmZX-nWiqn8a9keeb5sxi_x_lthyxnK4GWaiKfxZTIxoJ5gAfPIg4XJLP-LxRGe0KYeESvGtBTALOOrLcX4rM42zhlQ9jjyyKvG7C4M_Z_qenT5Xz4jN7pHg77s94aHj8kWMFCOZCCMt0mrmszsE2B51eipcyVKvly19_4B1AFjzw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKK1VcEG8CBYyEBJeoiWPHNuKyha7apa2QoKgXZDl2Qle0SbWbReqNv8Hf45cwk8eqWR7i7HGUeDz-vsmMZwh5rjVwgMLz0DnHQy7BpGwhfZi6yNsYKB1rujUcHqV7x3xyIk7WyOv-LkyT7d6HJNs7DVilqay3L3zRmrhKtwHzohCAFWw1TPg1sqGE1uB6bYxGkw-T_iTm4E2orlDj77MGQLR6HF_Bo9VcyZWAaYND45vkRkcg6ajV-C2ylpe3yeZhFyK_Qz6D4inmDNKqoLs7n-i0pEDyKLYerr7gyTad49DOYvZ1Wtc_v_-Y04NL0Gl1bl9RW9L9uvn1QU-7jiIUgc7T-WL2Lb-8S47Hux_f7IVdD4XQAVGoQxZnmdReFZ55y3Rki9imwoucMS8dyyx8GCB0nOkCiI1VUrqcJ86C4Que-Dy5R9bLqswfEFqANwvgnyqJP45kYoFKFFEeaQVPdywKSNgvqHFdgXHsc3FmGkdDpQYVYFABRpuEB-TFUv6iLa3xd0nUj0Gbgyc6210dgPfC6lVmBLQzBY9agOTWQBJsxQ2Hew2bzlbnBj08jTWNZECeLYdxJuaflXm1QBlMZkm4Ev-SEYA6kkUsIPfbTbP8LiYSjJCqgMjBdloKYJXv4Ug5PW2qfXMGlFkkAXnZb7wrr_7H5Xr4_6JPyeb7t2NzsH_07hG5DmSQIy7HYous17NF_hgIV5096ezqFyhRJG8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+EBV+in+the+pathogenesis+of+Burkitt%E2%80%99s+Lymphoma%3A+an+Italian+hospital+based+survey&rft.jtitle=Infectious+agents+and+cancer&rft.au=Pannone%2C+Giuseppe&rft.au=Zamparese%2C+Rosanna&rft.au=Pace%2C+Mirella&rft.au=Pedicillo%2C+Maria+Carmela&rft.date=2014-10-15&rft.pub=BioMed+Central&rft.eissn=1750-9378&rft.volume=9&rft_id=info:doi/10.1186%2F1750-9378-9-34&rft_id=info%3Apmid%2F25364378&rft.externalDocID=PMC4216353 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-9378&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-9378&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-9378&client=summon |